Verenium to Present at Jefferies 11th Global Clean Technology Conference
Share:
SAN DIEGO, Feb. 16, 2011 - Verenium Corporation (Nasdaq: VRNM), a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced that James Levine, Executive Vice President and Chief Financial Officer, will present at the upcoming Jefferies 11th Global Clean Technology Conference. The presentation is scheduled to begin at 1:30 p.m. EST on Wednesday, February 23, 2011 in New York City.
More information about this event, including a live webcast, may be accessed by visiting the "Investors" section of Verenium's website at www.verenium.com. A webcast replay will be available approximately one hour after the live webcasts end and will be accessible for one month following these conferences.
About Verenium
Verenium Corporation is a pioneer in the development and commercialization of high-performance enzymes for use in industrial processes. Verenium currently sells enzymes developed using its R&D capabilities to industrial customers globally for use in markets including grain and oilseed processing, biofuels, animal health and nutrition and other specialty industrial processes. Verenium has built a world-class R&D organization renowned for its capabilities in the rapid screening, identification, evolution and bioengineering of novel enzymes that act as catalysts for biochemical reactions. The company harnesses the power of nature and uses its unique, patented technology to create products that transform industries by maximizing efficiency while improving environmental performance. For more information on Verenium, visit www.verenium.com.
SOURCE Verenium Corporation
CONTACT: Kelly Lindenboom, Vice President, Corporate Communications, +1-617-674-5335, kelly.lindenboom@verenium.com; or Sarah Carmody, Manager, Corporate Communications, +1-617-674-5357, sarah.carmody@verenium.com, both of Verenium Corporation
Web Site: www.verenium.com
